Possible dilution is just that, possible. It's funny to see the stampede for the exits at the drop of the D word, almost like the C word (Cornell) was mentioned. And then to see all of those shares, plus some, scooped up before the close (BTW, it's not often one of these micro cap stocks is this bullish going into the close on the Friday of a three day weekend on no news, let alone with the "possible" bad news looming)...
PokerVertigo, I have to admit that you're right about the management not being top notch. I'm sure it's written somewhere that scientists don't make the greatest CEO's, as rednecks aren't the best choices for president.
That being said, Dr. P isn't some geek fresh out of bio school trying to cure cancer with flowers. He's a seasoned vetern in his field recognized by big pharma companies, especially so by the one he sued and won.
He also has justifiable concerns of a hostile takeover by one of these big pharma companies. They would rather run XKEM into the ground than lose all their massive profits selling products that don't work so hot, or have serious side affects.
What is 5 billion A/S? A drop in the bucket in the micro cap world. But if the mention of that possibility sends the weak hands running, I just hope management is smart enough to realize they could stop a hostile takeover attempt by buying up all the shares nobody else wants and locking them away for brighter days.
September is Sickle Cell awareness month, and I wouldn't be surprised to see news of a loan or two in the not so distant future. Someone's been accumulating the past few days as well it seems, even after the rush for the door Friday morning. One thing I can assure you, we'll be hearing some news about XKEM before the shareholder's meeting in October.